{
    "answer": "HR+/HER2- stage II and III early breast cancer (eBC) at high risk of recurrence",
    "ground_truth": "Treating hormone receptor-positive/human epidermal growth factor receptor 2-negative early breast cancer (adjuvant)",
    "rewards": [
        0,
        0,
        0
    ],
    "reward_sum": 0,
    "turns": 3,
    "search count": 2,
    "script count": 0,
    "summary count": 0,
    "context lengths": [
        898,
        2343,
        3582
    ]
}